FUNGAL COMPLICATIONS IN A PATIENT UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Filip Przemysław Krzanowski; Anna Halot; Małgorzata Kozioł; Jacek Krzanowski

doi:10.5114/hpc.2025.150236

eISSN: 2354-0265
ISSN: 2353-6942

Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO

Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Send email

Copy url:

Case report

FUNGAL COMPLICATIONS IN A PATIENT UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Filip Przemysław Krzanowski

¹

,

Anna Halot

¹

,

Małgorzata Kozioł

²

,

Jacek Krzanowski

³

Students Scientific Association at the Chair and Department of Medical Microbiology, Medical University of Lublin, Poland
Department of Medical Microbiology, Medical University of Lublin, Poland
Department of Hematology-Oncology, Specialist Hospital in Brzozow, Poland

Health Problems of Civilization

DOI: https://doi.org/10.5114/hpc.2025.150236

Online publish date: 2025/05/19

Article file

- Krzanowski et al.pdf [0.39 MB]

Get citation

PlumX metrics:

1. Zhou S, Aitken SL. Prophylaxis against Pneumocystis jirovecii pneumonia in adults. JAMA. 2023; 330(2): 182-3.

2. Coda JE, Raser K, Anand SM, Ghosh M, Maciejewski J, Pawarode A, et al. Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplant recipients. Blood. 2021; 138(Suppl 1): 4898. https://doi.org/10.1182/blood-2021-144633

3. Stavi V, Desai N, Michelis FV, Kim DDH, Kumar R, Lipton JH, et al. Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation: a retrospective study. Eur J Haematol. 2023; 110(6): 573-80.

4. McCollam S, Lewis JS, Bubalo J, Diaz A. Pneumocystis jirovecii pneumonia prophylaxis with intravenous pentamidine in allogeneic hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2022; 66(10): e00833-22. https://doi.org/10.1128/aac.00833-22

5. Haseeb A, Abourehab MAS, Almalki WA, Almontashri AM, Bajawi SA, Aljoaid AM, et al. Trimethoprim-Sulfamethoxazole dose optimization in Pneumocystis jirovecii pneumonia management: a systematic review. Int J Environ Res Public Health. 2022; 19(5): 2833. https://doi.org/10.3390/ijerph19052833

6. Li Y, Liu H, Lv Q, Long J. Diagnosis model of early Pneumocystis jirovecii pneumonia based on convolutional neural network: a comparison with traditional PCR diagnostic method. BMC Pulm Med. 2024; 24: 205. https://doi.org/10.1186/s12890-024-02987-x

7. Chen RY, Li DW, Wang JY, Zhuang SY, Wu HY, Wu JJ, et al. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in kidney transplant recipients. Transpl Infect Dis. 2022; 24(6): e13908. https://doi.org/10.1111/tid.13908

8. Alshahrani MY, Alfaifi M, Ahmad I, Alatawi RA, Alzahrani M, Alqurashi M, et al. Pneumocystis jirovecii detection and comparison of multiple diagnostic methods with quantitative real-time PCR in patients with respiratory symptoms. Saudi J Biol Sci. 2020; 27(6): 1423-7. https://doi.org/10.1016/j.sjbs.2020.04.032

9. Hsu JM, Hass A, Gingras MA, Avila JL, Tran TD, Chen S, et al. Radiographic features in patients investigated for Pneumocystis jirovecii pneumonia: a nested case-control study. BMC Infect Dis. 2020; 20(1): 492. https://doi.org/10.1186/s12879-020-05217-x

10. Nagai T, Matsui H, Fujioka H, Homma Y, Otsuki A, Ito H, et al. Low-dose vs conventional-dose Trimethoprim-Sulfamethoxazole for treatment of Pneumocystis jirovecii pneumonia. Chest. 2023; 164(2): 312-9. https://doi.org/10.1016/j.chest.2023.05.026

11. Masaki T, Ishikawa K, Fujino T, Koyamada R, Kawai F, Ota E, et al. Intermittent versus daily Trimethoprim/Sulfamethoxazole regimens for Pneumocystis pneumonia prophylaxis: a systematic review and meta-analysis. Open Forum Infect Dis. 2022; 9(4): ofae499. https://doi.org/10.1093/ofid/ofae499

Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

FUNGAL COMPLICATIONS IN A PATIENT UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Filip Przemysław Krzanowski 1 , Anna Halot 1 , Małgorzata Kozioł 2 , Jacek Krzanowski 3

Filip Przemysław Krzanowski

¹

,

Anna Halot

¹

,

Małgorzata Kozioł

²

,

Jacek Krzanowski

³